Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1128533

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatitis: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS Long Term Plan, what plans the Government has to allocate funding for research into chronic pancreatitis.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257709
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>The NHS Long Term Plan is a 10-year strategy for the National Health Service. It sets out how the NHS will spend the £33.9 billion cash terms annual increase going into the NHS budget by 2023/24. Research on health and social care continues to be funded by the Government through the National Institute for Health Research (NIHR). The future of budgets outside of the NHS England resource settlement will be confirmed later this year at Spending Review 2019.</p><p>The NIHR welcomes funding applications for research into any aspect of human health, including chronic pancreatitis. As with other major research funders, the NIHR does not ring-fence funds for particular topics or conditions. Applications for funding are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p><br> The NIHR’s funding and support for research into chronic pancreatitis which is currently ongoing or recently concluded (in financial year 2018/19) includes one directly funded study, with a total award of £262,500, investigating the use of antioxidants and magnesium for the treatment of pain in hereditary and idiopathic chronic pancreatitis. In addition, there has been NIHR support for two studies through its early translational research infrastructure and five through the NIHR’s Clinical Research Network, which provides support for delivering research funded by the NIHR itself and other public, charity and industry research funders.</p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 05/06/2019 16:26:33 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1533 label Biography information for Dame Diana Johnson

1128536

	registered interest
	date	23/05/2019
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Transport: North of England
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, what the (a) start and (b) end dates are for his Department's investment programmes for transport in the north by 2020.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257710
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>The Government funds a wide range of transport investment in the North. The start and end dates of the main transport programmes which will benefit the North by 2020 are as follows:</p><table><tbody><tr><td><p>Roads Investment Fund</p></td><td><p>2015/16 to 2019/20</p></td></tr><tr><td><p>Rail investment in Control Period 5</p></td><td><p>2014/15 to 2018/19</p></td></tr><tr><td><p>Rail investment in Control Period 6</p></td><td><p>2019/20 to 2023/24</p></td></tr><tr><td><p>Large Local Majors Funding</p></td><td><p>2015/16 to 2020/21</p></td></tr><tr><td><p>Transforming Cities Fund</p></td><td><p>2018/19 to 2022/23</p></td></tr><tr><td><p>Future Mobility Zones</p></td><td><p>2018/19 to 2022/23</p></td></tr><tr><td><p>Local Growth Funding</p></td><td><p>2015/16 to 2020/21</p></td></tr><tr><td><p>Integrated Transport Block</p></td><td><p>2015/16 to 2020/21</p></td></tr><tr><td><p>Highways Maintenance Fund</p></td><td><p>2015/16 to 2020/21</p></td></tr></tbody></table> answering member constituency Northampton North answering member printed Michael Ellis question first answered 05/06/2019 12:33:11 answering member 4116 label Biography information for Sir Michael Ellis
	tabling member	1533 label Biography information for Dame Diana Johnson

1128423

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases: Life Expectancy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the life expectancy of patients with sickle cell disease since 2000; and what steps he is taking to increase life expectancy for people suffering from that disease.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257501
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>Evidence suggests that life expectancy for people with sickle cell disease is improving. This is due to a number of factors including;</p><p>- Improved new born screening coverage to enable earlier diagnosis;</p><p>- Use of the National Haemoglobinopathy Registry to monitor individuals’ health, treatment and their annual reviews;</p><p>- Access to specific diagnostics and medication, such as hydroxyurea; and</p><p>- A Commissioning for Quality and Innovation incentive has been in place for the last two years to improve access to apheresis for individuals with sickle cell disease.</p><p>These factors are reflected in NHS England’s service specification quality indicators which providers are required to report against so that implementation can be monitored.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 05/06/2019 14:30:29 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson

1128424

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to engage with people affected by dementia on the development of the liberty protection safeguards code of practice.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257502
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>The Department is currently collaborating closely with stakeholders, including those with lived experience, to produce the Liberty Protection Safeguards Code of Practice. It is engaging with the third sector, health and social care organisations, user-led groups and individuals. This includes organisations which represent individuals with dementia and those affected by it, for example the Alzheimer’s Society and Carers UK.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 05/06/2019 13:45:32 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1533 label Biography information for Dame Diana Johnson

1128425

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pancreatitis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the number of people living with a diagnosis of chronic pancreatitis.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257503
	answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>No estimate has been made. However, the National Institute for Health and Care Excellence (NICE), in its guidance ‘Pancreatitis’, published September 2018, states that the annual incidence of chronic pancreatitis in western Europe is about five cases per 100,000 people. The male to female ratio is 7:1 and the average age of onset is between 36 and 55. The NICE guideline can be found at the following link:</p><p><a href="http://www.nice.org.uk/guidance/ng104" target="_blank">www.nice.org.uk/guidance/ng104</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 05/06/2019 14:16:47 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson